ARCHIVES

In Brief: Chabner Says He ”Has No Intention Of Leaving NCI; “Yarbro Named Clinical Indicators Chairman

This article is from The Cancer Letter archive.

Vol. 14 No. 36 | September 2, 1988

Download PDF Visit The Full Archive

Related Articles

DCT Board Restores Funding to Rosenberg’s Lymphocyte Projects

June 17, 1994

GSK’s Votrient Approved For Advanced Kidney Cancer

October 30, 2009

Amgen Says ESA Use Dropped By Half In Fourth Quarter.

January 25, 2008

Tobacco Control: Cigarette Price Hikes Reduce Smoking, Study Confirms

August 7, 1998

New NCAB Chair Seeks Ideas, Opinions On Cancer Priorities

September 23, 1994

ACS Recommends MRI For Some Women At High Risk

March 30, 2007